Shanghai Allist Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XJ7
CNY
116.50
-4.28 (-3.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Shanghai Allist Pharmaceuticals Co., Ltd.

Why is Shanghai Allist Pharmaceuticals Co., Ltd. ?

1
The company has declared Positive results for the last 10 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 2,163.79 MM
  • NET PROFIT(HY) At CNY 1,187.76 MM has Grown at 59.72%
  • ROCE(HY) Highest at 34.9%
2
With ROE of 29.16%, it has a attractive valuation with a 7.88 Price to Book Value
  • Over the past year, while the stock has generated a return of 14.68%, its profits have risen by 65.8%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Shanghai Allist Pharmaceuticals Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Allist Pharmaceuticals Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shanghai Allist Pharmaceuticals Co., Ltd.
29.73%
1.20
37.77%
China Shanghai Composite
3.56%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
173.97%
EBIT Growth (5y)
58.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.66
Tax Ratio
14.09%
Dividend Payout Ratio
20.56%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
39.07%
ROE (avg)
10.46%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
5.43
EV to EBIT
15.14
EV to EBITDA
14.95
EV to Capital Employed
8.48
EV to Sales
6.86
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
56.00%
ROE (Latest)
30.78%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 2,757.41 MM

ROCE(HY)

Highest at 36.71%

NET SALES(Q)

Highest at CNY 1,736.01 MM

OPERATING PROFIT(Q)

Highest at CNY 855.73 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 4.68 times

DIVIDEND PER SHARE(HY)

Highest at CNY 10.92

OPERATING PROFIT MARGIN(Q)

Highest at 49.29 %

PRE-TAX PROFIT(Q)

Highest at CNY 1,051.61 MM

NET PROFIT(Q)

Highest at CNY 898.08 MM

EPS(Q)

Highest at CNY 2.01

-3What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Shanghai Allist Pharmaceuticals Co., Ltd.

Operating Cash Flow
Highest at CNY 2,757.41 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales
Highest at CNY 1,736.01 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (CNY MM)

Operating Profit
Highest at CNY 855.73 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (CNY MM)

Net Sales
At CNY 1,736.01 MM has Grown at 22.41%
over average net sales of the previous four periods of CNY 1,418.18 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit Margin
Highest at 49.29 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CNY 1,051.61 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 898.08 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 2.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio
Highest at 4.68 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Dividend per share
Highest at CNY 10.92
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)